Data / Research funding / New Mexico / Exhalix, LLC
Exhalix, LLC: 6 NIH awards ($3.7M), fiscal years 2021 to 2026
Exhalix, LLC in Albuquerque, NM is funded under 6 NIH awards ($3.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- C1NVZ5M6E319
- State
- New Mexico
Awards
6 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| HEALS™: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $1,960,744 | September 20, 2021 | August 31, 2025 | SHEKARRIZ, REZA | reporter.nih.gov |
| Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease | NIH | National Heart, Lung, and Blood Institute | 2022 | $500,000 | September 6, 2014 | August 14, 2024 | SHEKARRIZ, REZA | reporter.nih.gov |
| Genie:S: On-Demand Sulfide Synthesis and Delivery Platform Technology for Ischemia Therapy | NIH | National Center for Advancing Translational Sciences | 2025 | $350,000 | September 16, 2025 | September 15, 2027 | SHEKARRIZ, REZA | reporter.nih.gov |
| Repair by Local Infusion of Sulfides (ReLIS™) for Treatment of Disadvantaged Surgical Incisions | NIH | National Institute on Aging | 2022 | $300,396 | August 15, 2022 | January 31, 2024 | SHEKARRIZ, REZA | reporter.nih.gov |
| HEALS™: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing | NIH | National Institute of General Medical Sciences | 2021 | $300,000 | September 20, 2021 | September 19, 2022 | SHEKARRIZ, REZA | reporter.nih.gov |
| A Hydrogen Sulfide Delivery Technology for Organ Preservation Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $248,492 | September 15, 2025 | August 31, 2027 | SHEKARRIZ, REZA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 2 | $598,492 | 0 | $0 |
| 2024 | 1 | $715,874 | 0 | $0 |
| 2023 | 1 | $1,244,870 | 0 | $0 |
| 2022 | 2 | $800,396 | 0 | $0 |
| 2021 | 1 | $300,000 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Bioengineering
- Cardiovascular
- Wound Healing and Care
- Diabetes
- Regenerative Medicine
- Biotechnology
- Cancer
- Aging
- Atherosclerosis
- Clinical Research
- Clinical Trials and Supportive Activities
- Health Disparities
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.